Economic outcomes and costs in the treatment of schizophrenia
Clinical Therapeutics 19 1 128-138
Abstract
Schizophrenia is an expensive illness, with hospitalization representing a major cost of treatment. To evaluate new drugs and management strategies for schizophrenia, we must have reliable measures of outcomes and costs. Cost-outcome evaluations are pa